BioAdaptives Inc.: 10-Q filed 2021-11-10
What BioAdaptives Inc. reported in its quarterly report filed 2021-11-10 (fiscal Q3 2021): 26 published measures, 79 facts as tagged in accession 0001640334-21-002736.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-11-10
- Fiscal period
- fiscal Q3 2021
- Accession
- 0001640334-21-002736 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioAdaptives Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 178,695 | USD | |
| At 2020-12-31 | 18,846 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 1,390,981 | USD | |
| At 2020-12-31 | 1,397,631 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -1,212,286 | USD | |
| At 2021-06-30 | -1,351,922 | USD | |
| At 2021-03-31 | -1,042,676 | USD | |
| At 2020-12-31 | -1,378,785 | USD | |
| At 2020-09-30 | -1,253,101 | USD | |
| At 2020-06-30 | -1,324,210 | USD | |
| At 2020-03-31 | -984,419 | USD | |
| At 2019-12-31 | -839,876 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -34,516 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -835,665 | USD | 273 |
| 2021-04-01 to 2021-06-30 | -309,246 | USD | 91 |
| 2021-01-01 to 2021-03-31 | -491,903 | USD | 90 |
| 2020-07-01 to 2020-09-30 | -13,463 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -681,820 | USD | 274 |
| 2020-04-01 to 2020-06-30 | -430,435 | USD | 91 |
| 2020-01-01 to 2020-03-31 | -237,922 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | -123,248 | USD | 273 |
| 2020-01-01 to 2020-09-30 | -97,027 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 5,342 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 15,925 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 4,439 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 12,596 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 185,000 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 99,163 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -6,441,826 | USD | |
| At 2020-12-31 | -5,606,161 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 163,900 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 47,115 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 77,278 | USD | |
| At 2020-12-31 | 18,846 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 64,543 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 141,792 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 66,213 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 178,717 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 1,390,981 | USD | |
| At 2020-12-31 | 1,397,631 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 175,968 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 467,310 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 25,711 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 240,991 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 9,601 | USD | |
| At 2020-12-31 | 13,815 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 3,115 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 8,963 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 1,051 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 4,491 | USD | 274 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 2,227 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 6,962 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 3,388 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 8,105 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 35,800,045 | shares | |
| At 2020-12-31 | 21,591,942 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 5,225,800 | USD | |
| At 2020-12-31 | 4,225,217 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 55,312 | USD | |
| At 2020-12-31 | 46,145 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -34,516 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -835,665 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -13,463 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -681,820 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 110,456 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 152,776 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 13,362 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 61,288 | USD | 274 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 92,083 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 138,337 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -377,318 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 11,197 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -445,320 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 16,424 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 1,079 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 0 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 0 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 4,214 | USD | 273 |
| 2020-01-01 to 2020-09-30 | -6,042 | USD | 274 |
Inspect the source
- Entity
- BioAdaptives Inc. / CIK 0001575142
- Captured
- 2026-09-20T09:21:44.555Z
- SEC response SHA-256
7d70ec2a8370eeb33cd7c2482065b30cf052619c39bb59e21df838c8d2f96db2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001575142.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))